tbuckley/cabot-search huggingface dataset:
P11-4 Efficacy and safety of anti-CD38 antibodies in combination with pomalidomide plus dexamethasone in patients with relapsed/refractory multiple myeloma
Authors: Tsuyoshi Sato, Kazuya Asano, Takahiro Maeta, Kazuki Kiyohara, Shinri Miyajima, Akihiro Otsu, Maki Nishiya, Ryousei Sasaki, Yoshiaki Okano, Satsuki Kamihara, Shugo Kowata, Tatsuo Oyake, Shigeki Ito
Journal: Annals of Oncology (2023)
MO41-6 Trastuzumab-deruxtecan and blood inflammatory markers in HER2-positive metastatic breast cancer
Authors: Mai Onishi, Tatsunori Shimoi, Rui Kitadai, Momoko Tokura, Shu Yazaki, Hitomi Sumiyoshi-Okuma, Motoko Arakaki, Ayumi Saito, Syosuke Kita, Kasumi Yamamoto, Aiko Maejima, Yuki Kojima, Tadaaki Nishikawa, Kazuki Sudo, Emi Noguchi, Yasuhiro Fujiwara, Kan Yonemori
Journal: Annals of Oncology (2023)
MO60-3 Clinical utility of gBRCA testing (BRACAnalysis) for patients with unresectable pancreatic cancer
Authors: Yasuharu Kawamoto, Takuo Yamai, Kenji Ikezawa, Yusuke Seiki, Ko Watsuji, Takeru Hirao, Sena Higashi, Makiko Urabe, Yugo Kai, Ryoji Takada, Kaori Mukai, Tasuku Nakabori, Hiroyuki Uehara, Tazuko Inoue, Fumie Fujisawa, Kazuyoshi Ohkawa
Journal: Annals of Oncology (2023)
MO41-3 Clinical significance of oncogenic miRNAs (21,17,10a &amp;10b) expression with breast cancer stem cells in breast carcinoma
Authors: Shailendra Dwivedi, Puneet Pareek, Jeewan Ram Vishnoi, Praveen Sharma, Sanjeev Misra, Surekha Kishore
Journal: Annals of Oncology (2023)
P57-5 A case report of primary unresectable hilar cholangiocarcinoma eventually causing colonic obstruction due to peritoneal dissemination after chemoradiation
Authors: Atsushi Toyofuku, Hiroaki Kuroda, Akiko Sakurai, Kohei Yoshida, Yugo Iha, Takehide Tajima, Yasuki Akiyama, Kotaro Kitahara, Ryota Murayama, Tatsuhiko Sako, Aiichiro Higure, Shinsaku Yamaguchi, Shinji Yotsumoto, Ken-Ichi Sakita, Naoki Nagata
Journal: Annals of Oncology (2023)
P50-5 Efficacy and safety of CBDCA/ETP/ICI combination therapy for extensive-stage small cell lung cancer in elderly patients
Authors: Naoto Fukasawa, Yukiko Nakamura, Kazuhito Miyazaki, Toshiki Ikeda, Yuko Higashi, Masaharu Aga, Yusuke Hamakawa, Yuri Taniguchi, Yuki Misumi, Yoko Agemi, Tsuneo Shimokawa, Hiroaki Okamoto
Journal: Annals of Oncology (2023)
MO28-6 Feasibility of the online-based QOL survey in patients with head and neck cancer. A multi-center, prospective study
Authors: Hiroto Ishiki, Tomomi Kobayashi, Hisayo Doi, Sayaka Arakawa, Koji Amano, Eriko Satomi, Yoshitaka Honma, Mitsumi Terada, Junki Mizusawa, Yuichiro Kikawa, Yoshinori Imamura, Taiji Koyama, Kayoko Nakano, Dagmara Kulis, Susanne Singer, Gerhard Rumpold, Bernhard Holzner, Andrew Bottomley, Naomi Kiyota
Journal: Annals of Oncology (2023)
MO25-4 Clinical outocomes of nivolumab plus ipilimumab in metastatic renal cell carinoma
Authors: Taigo Kato, Kazutoshi Fujita, Akira Nagahara, Wataru Nakata, Kyousuke Matsuzaki, Koji Hatano, Atsunari Kawashima, Shingo Takada, Kensaku Nishimura, Masao Tsujihata, Tetsuya Takao, Yasutomo Nakai, Masashi Nakayama, Kazuo Nishimura, Motohide Uemura, Hirotsugu Uemura, Norio Nonomura
Journal: Annals of Oncology (2023)
P32-8 An inter-facility linkage case for palliative care and cancer pharmacotherapy in the Kagawa Medical Information Network
Authors: Akitsu Murakami, Takamasa Nishiuchi, Kotone Nomura, Hiroe Shigeta, Hiroyuki Okuyama, Yoshihiro Okita, Ikuhiro Kita, Sena Tsukamoto, Sachiko Oue, Kazuyo Uematsu, Akihito Tsuji
Journal: Annals of Oncology (2023)
P47-1 FOLFOXIRI therapy with bevacizumab in metastatic colorectal cancer patient: Systematic review
Authors: Dion Ravinder Theodeus Subroto, Mario Sutanto, Natasha Karlina Law, Jonathan Vincent Lee, Chandni Kumar, Axel Sebastian Siregar, Andreas Sihombing, Xavier Manuel Ang, Andree Kurniawan
Journal: Annals of Oncology (2023)
MO46-1 A retrospective study on the development of osteonecrosis of the jaws (ONJ) in patients treated with bone modifying agents (BMA)
Authors: Taro Yamanaka, Kohji Takemura, Haruka Kono, Erisa Toda, Haruka Ozaki, Hiroki Okumura, Masahiro Kuno, Kazumasa Yamamoto, Shogo Watanabe, Rika Kizawa, Takeshi Yamaguchi, Yuko Tanabe, Masako Yanagawa, Koichi Suyama, Jumpei Sugizaki, Yuji Miura
Journal: Annals of Oncology (2023)
MO40-5 Early administration of pegfilgrastim contributes to the safety of DCF therapy as neoadjuvant chemotherapy for esophageal cancer
Authors: Ryuichi Morita, Takeshi Ishikawa, Yuki Endo, Takeshi Yasuda, Kaname Oka, Tomoki Sakakida, Shinya Matsumura, Katsura Mizushima, Toshifumi Doi, Tetsuya Okayama, Kazuhiro Katada, Kazuhiro Kamada, Kazuhiko Uchiyama, Tomohisa Takagi, Hitoshi Fujiwara, Hideyuki Konishi, Yoshito Itoh
Journal: Annals of Oncology (2023)
MO58-4 CDK4/6 inhibitors as maintenance therapy after initial chemotherapy: A retrospective single-institute study
Authors: Fumie Fujisawa, Takahiro Nakayama, Yoshiki Kojitani, Azusa Taniguchi, Satomi Nakajima, Haruka Kanaoka, Saya Kitashiro, Yuri Ooyama, Yukiko Seto, Ai Soma, Yasunobu Ishizuka, Hiroki Kusama, Noriyuki Watanabe, Tomoyuki Otsuka, Saki Matsui, Minako Nishio, Naohiro Nishida, Naotoshi Sugimoto, Toshinari Yagi, Toshihiro Kudo
Journal: Annals of Oncology (2023)
MO35-3 Comparison of clinical outcomes between 1st-line osimertinib, 1G/2G EGFR-TKIs followed by osimertinib and without osimertinib
Authors: Yuji Uehara, Tatsuya Yoshida, Yuki Takeyasu, Akiko Tateichi, Masahiro Torasawa, Ken Masuda, Yuki Shinno, Yuji Matsumoto, Yusuke Okuma, Yasushi Goto, Hidehito Horinouchi, Noboru Yamamoto, Yuichiro Ohe
Journal: Annals of Oncology (2023)
P29-8 A study of lung cancer cases who participated in cancer genome medicine at our hospital
Authors: Masahiko Sumii, Masashi Namba, Kentaro Tokumo, Masami Yamauchi, Hikaru Nakahara, Yuji Urabe, Nelson Hayes, Ryo Itamura, Masanori Motonaga, Shinjiro Sakamoto, Kakuhiro Yamaguchi, Takeshi Masuda, Kazunori Fujitaka, Wataru Okamoto, Koji Arihiro, Eiso Hiyama, Noboru Hattori, Takao Hinoi, Kazuhiko Sugiyama
Journal: Annals of Oncology (2023)
P25-3 Prognostic impact of concomitant antacids in EGFR-mutation-positive NSCLC: The Tokushukai REAl-world Data project (TREAD 01-S2)
Authors: Kiyoaki Uryu, Yoshinori Imamura, Rai Shimoyama, Takahiro Mase, Yoshiaki Fujimura, Maki Hayashi, Megu Ohtaki, Keiko Otani, Nobuaki Shinozaki, Hironobu Minami
Journal: Annals of Oncology (2023)
MO36-2 Updated analysis from a phase II study on the efficacy of nivolumab in patients with cancer of unknown primary (NivoCUP)
Authors: Yohei Funakoshi, Junko Tanizaki, Kan Yonemori, Kohei Akiyoshi, Hiroki Ueda, Yuichi Takiguchi, Yuji Miura, Yoshihiko Segawa, Keigo Komine, Yoshiko Okikawa, Yasuhiro Kidera, Kazuya Fukuoka, Akihiko Ito, Yasutaka Chiba, Kazuko Sakai, Hironobu Minami, Kazuto Nishio, Kazuhiko Nakagawa, Hidetoshi Hayashi
Journal: Annals of Oncology (2023)
P19-10 A case of non-invasive therapy for unresectable desmoid fibromatosis with perforation of the gastrointestinal tract
Authors: Hiroaki Miyake, Koji Iwashita, Shunsuke Imamura, Nozomu Ogura, Mai Hoshino, Satoshi Kaneda, Shigemichi Hirose, Shinsuke Funakoshi
Journal: Annals of Oncology (2023)
MO14-6 CT-based AI machine learning model for predicting efficacy of chemoradiotherapy for esophageal squamous cell carcinoma
Authors: Akinari Kasai, Jinsei Miyoshi, Akihiro Haga, Takashi Kawanaka, Hiroshi Miyamoto, Yasushi Sato, Tetsuji Takayama
Journal: Annals of Oncology (2023)

Chemoradiotherapy (CRT) is one of the most effective treatments for esophageal squamous cell carcinoma (ESCC) because CRT is potentially curable and less invasive than surgery. However, there is no useful biomarker for predicting the response and prognosis of CRT for ESCC. Therefore, we developed non-invasive and low-cost CT-based machine learning model for efficacy prediction of CRT in ESCC by radiomics analysis. We enrolled 44 patients with ESCC (stage I - IV) and analyzed the CT images of cancer. The 476 radiomics features were extracted from the CT data of each cancer in training cohort (n=27). We extracted 12 radiomics features significantly associated with the CRT responder from CT images. We then constructed an algorithm to predict response to CRT based on the 12 features and response, employing 5 kinds of machine learning methods (random forest (RF), ridge regression (RR), naïve bayes (NB), support vector machine (SVM), and artificial neural network models (ANN)), Of these, the RF model showed the highest AUC value of 0.99 (p<0.001, accuracy of 77.8%, sensitivity of 100%, specificity of 71.4%). The other classifiers also showed high diagnostic rates with AUC values ranging 0.95 to 0.98. We then evaluated ROC curves in validation cohort (n=17). The optimal cutoff value was set as 0.18 by the Youden index. Similarly, the RF model showed the highest AUC value of 0.92 (p<0.001, accuracy of 82.4%, sensitivity of 83.3%, specificity of 81.8%). NB and RR models also showed high AUC values of more than 0.8. Using the data of all patients, we evaluated whether the RF model is able to predict prognosis as well. The Kaplan-Meier analysis revealed that our model could successfully predict long-term response after CRT such as PFS (30.2 vs 5.9 months, p<0.0001) and OS (100.4 vs 13.0 months, p<0.0001). Thus, we successfully established a non-invasiveness and low cost AI-based radiomics model that can predict CRT response and prognosis of ESCC with very high accuracy.
P67-5 Our experience with immune checkpoint inhibitors in triple-negative breast cancer patients
Authors: Minako Nishio, Yoshiki Kojitani, Saya Kitashiro, Yasunobu Ishiduka, Tomoyuki Otsuka, Naohiro Nishida, Fumie Fujisawa, Naotoshi Sugimoto, Toshinari Yagi, Ai Souma, Haruka Kanaoka, Yuri Oyamayama, Azusa Taniguchi, Satomi Nakajima, Yukiko Seto, Hiroki Kusama, Noriyuki Watanabe, Saki Matsui, Takahiro Nakayama, Toshihiro Kudou
Journal: Annals of Oncology (2023)
MO72-1 Current status and problems of comprehensive cancer genome profiling test in biliary tract and pancreatic cancer in our institutions
Authors: Hiroyuki Okuyama, Sena Tsukamoto, Ikuhiro Kita, Akitsu Murakami, Yoshihiro Okita, Kotone Nomura, Takamasa Nishiuchi, Akihito Tsuji
Journal: Annals of Oncology (2023)
MO31-5 A project to investigate the actual status of biomarker testing in unresectable advanced or recurrent non-small cell lung cancer: WJOG15421 L (REVEAL)
Authors: Yosuke Kawashima, Tomohiro Sakamoto, Taichi Matsubara, Takayuki Takahama, Shinya Sakata, Maeda Tadashi, Ichiro Yoshino, Kenji Nagata, Akito Hata, Kenji Sugio, Tomoyoshi Takenaka, Morihito Okada, Kunihiro Nishimura, Manabu Hiraoka, Hirotsugu Kenmotsu, Junya Hujimoto, Mototsugu Shimokawa, Wakayama Medical University, Kazuhiko Nakagawa
Journal: Annals of Oncology (2023)
MO69-6 The possibility of microtubule-related agents as a new treatment option for neuroendocrine carcinoma and small cell lung cancer
Authors: Satoru Yamaga, Hiroshi Ariyama, Takashi Imajima, Shohei Ueno, Koki Uehara, Sakuya Koreishi, Ryosuke Taguchi, Kenro Tanoue, Eishi Baba
Journal: Annals of Oncology (2023)
P31-9 A retrospective study of elderly and non-elderly patients with metastatic pancreatic cancer treated with GEM+nab-PTX therapy
Authors: Yasuyuki Kawamoto, Kazuaki Harada, Takahiro Yamamura, Ryosuke Watanabe, Takeaki Nakamura, Satoshi Yuki, Masaki Kuwatani, Yoshito Komatsu, Naoya Sakamoto
Journal: Annals of Oncology (2023)
MO54-1 Kynurenine-to-tryptophan ratio in solid cancer patients receiving ChAdOx1-nCoV-19 vaccine
Authors: Bunnatut Panasawatwong, Phacharaphon Khlaiphayak, Noppawan Phumala Morales, Paveena Yamanont, Ampai Prasomphol, Chada Sartsuk, Supreeya Preaprang, Hathairat Choengsamor, Rungthong Phongwan, Pimtip Sanvarinda, Passakorn Wanchaijiraboon
Journal: Annals of Oncology (2023)
P8-5 Calculation of medical personnel expenses to conduct a comprehensive genomic profiling test in Japan
Authors: Hidenori Kage, Katsutoshi Oda, Manabu Muto, Katsuya Tsuchihara, Natsuko Okita, Yusuke Okuma, Junko Kikuchi, Hidekazu Shirota, Hideyuki Hayashi, Toshio Kokuryo, Daisuke Sakai, Akira Hirasawa, Makoto Kubo, Hirotsugu Kenmotsu, Nana Akiyama, Aya Shinozaki-Ushiku, Masahiko Tanabe, Tetsuo Ushiku, Kiyoshi Miyagawa, Yasuyuki Seto
Journal: Annals of Oncology (2023)
MO21-6 Efficacy and safety of chemotherapy in metastatic malignant phyllodes tumors
Authors: Aya Takigawa, Kenta Nio, Kohei Arimizu, Mamoru Ito, Kenji Tsuchihashi, Daichi Isobe, Hiroshi Ariyama, Koji Ide, Yuzo Matsushita, Risa Tanaka, Akashi Koichi, Eishi Baba
Journal: Annals of Oncology (2023)
P27-9 Severe hypocalcemia due to osteoblastic metastases in a patient with metastatic prostate cancer: A case report
Authors: Ratchanon Tamamritkul, Thanyanan Baisamut, Phichai Chansriwong, Wallaya Jongcharoenprasert, Thitiya Dejthevaporn, Thanate Dajsakdipon
Journal: Annals of Oncology (2023)
MO26-4 The impact and emerging issues of confirmation of chemotherapy regimen by a pharmacist in our breast oncology
Authors: Rie Ozeki, Junichiro Watanabe, Hyonmi Sai, Misato Okazaki, Yasuko Kikuchi, Toshitaka Uomori, Hideo Shimizu, Yoshiya Horimoto, Kotaro Iijima, Mitsue Saito
Journal: Annals of Oncology (2023)
P8-3 Time course of cancer genome panels at Osaka Red Cross Hospital
Authors: Takanobu Shimada, Takehiko Tsumura, Keitaro Doi, Kaori Taniguchi, Yuki Fujimura, Noriko Akimaru, Shigeru Tsuyuki, Hiroki Tado, Maho Konishi, Toshihide Shimada, Kazunori Imada, Masafumi Kanai, Masahiro Yoshioka, Keita Fukuyama, Manabu Muto
Journal: Annals of Oncology (2023)
MO59-6 Karyopherin alpha 2 (KPNA2) predicts prognosis in breast cancer patients: A systematic review and meta-analysis
Authors: Michael G. Lokanata, Jeremiah H. Wijaya, Alexander E. Purnomo, Rivaldo S. Heriyanto, Yang Yang E Arjuna, Regan Elbert, Andree Kurniawan
Journal: Annals of Oncology (2023)
MO27-1 Psychosocial risk factors of chronic pain among post-surgical breast cancer survivors: A systematic review
Authors: Felix Wijovi, Angeline Tancherla, Rivaldo Steven Heriyanto, Patricia Angel, Natasya Reina, Gisela Meydilin Sanjaya, Fernando Dharmaraja, Darien Alfa Cipta, Andree Kurniawan
Journal: Annals of Oncology (2023)
MO63-2 Overall survival for esophageal cancer patients with pembrolizumab: Systematic review
Authors: Mario Sutanto, Dion Ravinder Theodeus Subroto, Natasha Karlina Law, Jonathan Vincent Lee, Chandni Kumar, Axel Sebastian Siregar, Xavier Manuel Ang, Andreas Sihombing, Andree Kurniawan
Journal: Annals of Oncology (2023)

Esophageal cancer is the sixth most common cancer worldwide, with a shallow survival rate. One alternative treatment is pembrolizumab, which is only indicated in patients who are ineligible for surgery and chemoradiation. However, the efficacy of pembrolizumab is still not apparent. Therefore, this study aims to investigate the overall survival (OS) of esophageal cancer when treated with pembrolizumab.
MO1-2 Subgroup analysis of atezo + bev + carbo + pac for previously treated patients with EGFRm NSCLC (NEJ043)
Authors: Jun Shiihara, Satoshi Watanabe, Naoki Furuya, Atsushi Nakamura, Ichiro Nakachi, Hisashi Tanaka, Mika Nakao, Koichi Minato, Masahiro Seike, Shinichi Sasaki, Akira Kisohara, Susumu Takeuchi, Ryoichi Honda, Kei Takamura, Hiroshi Kagamu, Kenichi Yoshimura, Toshiaki Kikuchi
Journal: Annals of Oncology (2023)
P53-2 A case of metastatic prostate cancer mimicking malignant lymphoma
Authors: Nae Itagaki, Kyosuke Seguchi, Yasutomo Miyaji, Suruga Saito, Akinori Kobayashi, Yuta Ishiyama, Hiroki Kontani, Takamori Ogawa, Hironori Kobayashi, Shoko Aoki, Yu Oyama
Journal: Annals of Oncology (2023)
P33-7 Two patients with DLBCL who developed aortitis following pegfilgrastim administration during chemoimmunotherapy
Authors: Mikako Tamba, Hiroaki Asai, Kikuaki Yoshida, Kei Hirano, Yukako Teramoto, Mitsuhito Hirano, Yuko Shirouchi, Yuko Ishihara, Yuko Mishima, Dai Maruyama
Journal: Annals of Oncology (2023)
MO39-1 CapeOX therapy for elderly pts with advanced gastric cancer (phase II study with geriatric assessment, TCOG GI-1601)
Authors: Osamu Muto, Keisho Chin, Ryohei Kawabata, Hisashi Hosaka, Yoshiaki Shindo, Naoki Nagata, Hiroshi Yabusaki, Tomono Kawase, Shunji Endo, Tomomi Kashiwada, Masato Nakamura, Jun Hihara, Michiya Kobayashi, Fumio Nagashima, Daisuke Takahari, Naoki Ishizuka, Kensei Yamaguchi
Journal: Annals of Oncology (2023)
MO28-5 Effectiveness of ketamine for depression among advanced cancer patients in palliative care: A systematic review
Authors: Darien Alfa Cipta, Felix Wijovi, Rivaldo Steven Heriyanto, Angeline Tancherla, Patricia Angel, Natasya Reina, Fernando Dharmaraja, Gisela Meydilin Sanjaya, Andree Kurniawan, Theo Audi Yanto
Journal: Annals of Oncology (2023)
MO42-6 Analysis of sperm preservation in patients with mediastinal germ cell tumor patients
Authors: Kotaro Umamoto, Ayumi Saito, Emi Noguchi, Yoshiko Takahashi, Rui Kitadai, Motoko Arakaki, Shu Yazaki, Momoko Tokura, Asuka Kawachi, Kasumi Yamamoto, Shosuke Kita, Yuki Kojima, Aiko Maejima, Eijiro Nakamura, Tadaaki Nishikwa, Tatsunori Shimoi, Kazuki Sudo, Kan Yonemori
Journal: Annals of Oncology (2023)
MO69-4 Clinical outcomes of everolimus for patients with advanced neuroendocrine tumors arising from the rectum: A single-institutional retrospective study
Authors: Yuntae Kim, Hidekazu Hirano, Shun Yamamoto, Natsuko Okita, Hirokazu Shoji, Yoshitaka Honma, Satoru Iwasa, Atsuo Takashima, Ken Kato
Journal: Annals of Oncology (2023)
MO38-2 Post-marketing surveillance of tepotinib for non-small cell lung cancer with MET exon 14 skipping mutations – final report
Authors: Terufumi Kato, Tatsuya Ogura, Masashi Sato, Risa Kojima, Bingbing Song, Eisuke Horii, Kazuhiko Nakagawa
Journal: Annals of Oncology (2023)
MO69-5 Contribution of neuroendocrine differentiation to prognosis in extrapulmonary small cell or neuroendocrine carcinoma
Authors: Nobuyuki Takahashi, Kanako Mamishin, Kaede Baba, Mao Uematsu, Hikari Kiyohara, Akira Hirota, Misao Fukuda, Shota Kusuhara, Hiromichi Nakajima, Takehiro Nakao, Chikako Funasaka, Chihiro Kondoh, Kenichi Harano, Nobuaki Matsubara, Yoichi Naito, Ako Hosono, Toru Mukohara
Journal: Annals of Oncology (2023)
P10-2 Prognostic value of systemic inflammation in patients undergoing 1st-line chemotherapy for metastatic pancreatic cancer: Tokushukai REAl-world Data project
Authors: Rai Shimoyama, Yoshinori Imamura, Kiyoaki Uryu, Takahiro Mase, Yoshiaki Fujimura, Maki Hayashi, Megu Ohtaki, Keiko Ohtani, Nobuaki Shinozaki, Hironobu Minami
Journal: Annals of Oncology (2023)
P20-2 The potency of utilization ANLC lipid nanoparticle technology from grapes extract in the management of breast cancer
Authors: Pande Ketut Raditya Adi Kusuma, Ketut Wahyu Megananda Kesuma Kesuma Putra, Made Bayu Permasutha S. ked., Ketut Suparna M. Si. Sp. B, Onk
Journal: Annals of Oncology (2023)
MO58-5 Abemaciclib-induced liver dysfunction in metastatic breast cancer
Authors: Toshiko Miyaki, Satoshi Yoshimura, Tamaki Tamanuki, Syoko Hayama, Rikiya Nakamura, Naohito Yamamoto, Chika Manako, Hideki Tsujimura, Kyoya Kumagai, Keiko Oshida, Masaki Oshida, Yasushi Ito
Journal: Annals of Oncology (2023)
MO39-5 Analysis of perioperative chemotherapy-mediated genomic changes in gastric cancer
Authors: Ko Ikegame, Hayato Omori, Masao Hada, Hideki Watanabe, Atsushi Takano, Ayako Kimura, Masayuki Inoue, Kazusige Furuya, Michiya Yasutome, Yoshiaki Miyasaka, Yuji Imuro, Hiroshi Nakagomi, Kenji Amemiya, Yosuke Hirotsu, Masao Omata
Journal: Annals of Oncology (2023)
MO39-4 Efficacy and safety of trifluridine/tipiracil as a salvage-line treatment for patients with advanced gastric cancer
Authors: Koshiro Fukuda, Daisuke Takahari, Hiroki Osumi, Izuma Nakayama, Shota Fukuoka, Mariko Ogura, Akira Ooki, Takeru Wakatsuki, Keitaro Shimozaki, Koichiro Yoshino, Eiji Shinozaki, Keisho Chin, Kensei Yamaguchi
Journal: Annals of Oncology (2023)
MO56-3 Incidence of synchronous or metachronous multiple cancers and their predictive factors in patients with non-small cell lung cancer
Authors: Takeshi Honda, Hiroki Kazahari, Ryosuke Ochiai, Masashi Ishihara, Shigeru Tanzawa, Hao Chen, Yasuko Ichikawa, Kiyotaka Watanabe, Nobuhiko Seki
Journal: Annals of Oncology (2023)
MO40-3 The impact of sarcopenia on adverse events during neoadjuvant chemotherapy in esophageal squamous cell carcinoma
Authors: Takayuki Tsuji, Hirofumi Kawakubo, Masashi Takeuchi, Satoru Matsuda, Kazumasa Fukuda, Rieko Nakamura, Yuko Kitagawa
Journal: Annals of Oncology (2023)
MO36-6 Factors related to family caregiver-perceived burden associated with testing and diagnosis of cancer of unknown primary
Authors: Kyoko Ishida, Shoko Ando, Kazuki Sato, Hirokazu Komatsu, Tatsuya Morita, Tatsuo Akechi, Megumi Uchida, Tomoyo Sahashi, Sayaka Yamamura, Tamami Adachi, Kento Masukawa, Igarashi Naoko, Yoshiyuki Kizawa, Satoru Tsuneto, Yasuo Shima, Mitsunori Miyashita
Journal: Annals of Oncology (2023)
MO61-6 Efficacy of third-line chemotherapy after liposomal irinotecan and fluorouracil with folinic acid for pancreatic cancer
Authors: Reina Kawasaki, Tsuyoshi Shirakawa, Mototsugu Shimokawa, Taiga Otsuka, Hisanobu Oda, Taro Shibuki, Junichi Nakazawa, Shiho Arima, Keisuke Miwa, Futa Koga, Yoshihito Kubotsu, Yujiro Ueda, Hozumi Shimokawa, Shigeyuki Takeshita, Azusa Komori, Ayumu Hosokawa, Tatsunori Sakai, Shuji Arita, Toshihiko Mizuta, Kenji Mitsugi
Journal: Annals of Oncology (2023)
MO62-7 Prognostic evaluation using cfDNA in patients with resectable lung cancer
Authors: Yuya Murase, Hayato Koba, Isao Matsumoto, Saya Tsukida, Masato Hongo, Yoshihiro Yamamoto, Tasuku Iwabuchi, Atsushi Muto, Takashi Kobayashi, Kazumasa Kase, Yoshihiro Takeda, Nanao Terada, Yuichi Tambo, Noriyuki Ohkura, Hideharu Kimura, Satoshi Watanabe, Johsuke Hara, Miki Abo, Seiji Yano
Journal: Annals of Oncology (2023)
MO35-1 Prognostic evolution of EGFR-mutated non-small cell lung cancer over the past 20 years since the beginning with gefitinib
Authors: Takahiro Nakagomi, Yonchin Kim, Naho Sato, Ritsuko Yokouchi, Rumi Higuchi, Toshiharu Tsutsui, Yumiko Kakizaki, Yoshihiro Miyashita, Taichiro Goto, Yosuke Hirotsu, Hitoshi Mochizuki, Masao Omata
Journal: Annals of Oncology (2023)
P22-1 Nivolumab combination chemotherapy (NC) for HER2-negative, unresectable, advanced, or recurrent gastric cancer (AGC): A retrospective observational study
Authors: Wakana Chikaishi, Akitaka Makiyama, Itaru Yasufuku, Hiroshi Tsuchiya, Hirokatsu Hayashi, Yuta Sato, Ryuichi Asai, Jesse Yu Tajiama, Chinatsu Makiyama, Shinya Uemura, Takashi Ibuka, Takuji Iwashita, Shigeru Kiyama, Yoshihiro Tanaka, Naoki Okumura, Katsutoshi Murase, Takao Takahashi, Masahito Shimizu, Nobuhisa Matsuhashi
Journal: Annals of Oncology (2023)
MO25-2 Clinical outcomes of systemic therapy for metastatic renal cell carcinoma patients on hemodialysis
Authors: Shun Iwasa, Ryuichi Mizuno, Yota Yasumizu, Nobuyuki Tanaka, Toshikazu Takeda, Kazuhiro Matsumoto, Shinya Morita, Takeo Kosaka, Hiroshi Asanuma, Mototsugu Oya
Journal: Annals of Oncology (2023)
P63-5 Cases of atypical femur fractures; the rare adverse events requiring the multidisciplinary team decision-making
Authors: Dan Kanehira, Takuro Mizukami, Keita Uchino, Yuki Ishikawa, Hiroko Kado, Sachio Shimizu, Shigemasa Takamizawa, Chiharu Tanai, Takashi Yamada, Akira Fukuda, Toshiaki Kato
Journal: Annals of Oncology (2023)
MO43-1 The treatment sequence of weekly paclitaxel, carboplatin, and cetuximab (PCE) followed by nivolumab for R/M SCCHN
Authors: Naohiro Takeshita, Tomohiro Enokida, Susumu Okano, Takao Fujisawa, Akihisa Wada, Masanobu Satou, Hideki Tanaka, Nobukazu Tanaka, Ryutaro Onaga, Yuta Hoshi, Makoto Tahara
Journal: Annals of Oncology (2023)
MO56-2 Efficacy of whole brain radiotherapy for patients with leptomeningeal metastasis of non-small cell lung cancer: NEJ049
Authors: Megumi Furuta, Eisaku Miyauchi, Aya Suzuki, Hironori Ashinuma, Daisuke Arai, Atushi Shimonishi, Shinobu Hosokawa, Takamasa Hotta, Minehiko Inomata, Satoshi Morita, Ryo Ko, Yusuke Okuma, Takaaki Sasaki, Kyoichi Kaira, Kunihiko Kobayashi, Hisatoshi Sugiura
Journal: Annals of Oncology (2023)
MO36-3 Clinical management of cancer of unknown primary with unfavorable subset: A retrospective analysis
Authors: Yasutaka Tono, Koushi Sukeno, Akira Tsunoda, Hiroki Oka, Mikiya Ishihara, Kanako Saito, Satoshi Tamaru, Yoshiki Yamashita, Takumi Fujiwara, Takahito Kitajima, Yoshinaga Okugawa, Toshiro Mizuno
Journal: Annals of Oncology (2023)